Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

© Synapse Social LLC, 2026

Política de privacidad

Immune gene expression in head and neck squamous cell carcinoma patients | Synapse

October 5, 2019Open Access

Immune gene expression in head and neck squamous cell carcinoma patients

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

OX40L and PDGFRB overexpression was associated with poor outcomes, whereas PD-1 overexpression was associated with good prognosis in patients with HNSCC treated with primary surgery, suggesting their relevance as potential prognostic biomarkers and major therapeutic targets.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Lecerf et al. (Sat,) studied this question.

synapsesocial.com/papers/69d8127d66a29169b4bee238 https://doi.org/https://doi.org/10.1016/j.ejca.2019.08.028

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers2006 · 598 citations
2Abstract P1-07-03: Evaluation of the prognostic value of CD3, CD8 and FOXP3 mRNA expression in early breast cancer patients treated with anthracycline-based adjuvant chemotherapy2018 · 1 citations
3Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck2006 · 5,107 citations
4Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma2016 · 37 citations
5Regression Models and Life-Tables1972 · 39,296 citations